We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IRMD market cap is 703.63M. The company's latest EPS is USD 1.3566 and P/E is 41.10.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.51M | 17.45M | 17.6M | 17.93M | 18.33M |
| Operating Income | 5.91M | 5.16M | 4.75M | 5.63M | 5.79M |
| Net Income | 5.07M | 4.54M | 4.14M | 4.9M | 5.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38.52M | 31.72M | 41.82M | 53.3M | 65.56M |
| Operating Income | 8.65M | -757k | 9.82M | 15.63M | 20.04M |
| Net Income | 9.63M | 1.37M | 9.33M | 12.83M | 17.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 87.41M | 92.16M | 88.01M | 89.95M | 94.25M |
| Total Liabilities | 12.84M | 20.74M | 11.89M | 10.28M | 10.81M |
| Total Equity | 74.57M | 71.42M | 76.12M | 79.67M | 83.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66.73M | 71.07M | 82.88M | 85.51M | 92.16M |
| Total Liabilities | 11.21M | 9.68M | 10.71M | 11.84M | 20.74M |
| Total Equity | 55.52M | 61.39M | 72.17M | 73.67M | 71.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.55M | 13.47M | 3.88M | 10.52M | 19.64M |
| Investing | -7.37M | -8.01M | -479k | -1.75M | -5.76M |
| Financing | -13.4M | -13.66M | -8.04M | -10M | -11.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.23M | 5.82M | 11.26M | 10.04M | 13.47M |
| Investing | 3.2M | 247k | 649k | -1.38M | -8.01M |
| Financing | 2.02M | 523k | 24k | -12.71M | -13.66M |
| Market Cap | 703.63M |
| Price to Earnings Ratio | 41.10 |
| Price to Sales Ratio | 10.78 |
| Price to Cash Ratio | 14.2 |
| Price to Book Ratio | 9.89 |
| Dividend Yield | 1.08% |
| Shares Outstanding | 12.67M |
| Average Volume (1 week) | 30.1k |
| Average Volume (1 Month) | 46.73k |
| 52 Week Change | 17.30% |
| 52 Week High | 57.95 |
| 52 Week Low | 40.18 |
| Spread (Intraday) | 22.13 (31.62%) |
| Company Name | iRadimed Corporation |
| Address |
2711 centerville road wilmington, delaware 19808 |
| Website | https://www.iradimed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
